Ammitzbøll, Gunn http://orcid.org/0000-0003-3227-9475
Hyldegaard, Ole http://orcid.org/0000-0002-1147-379X
Forchhammer, Martin
Rottensten, Henrik
Lanng, Charlotte
Kroman, Niels http://orcid.org/0000-0002-6631-2993
Zerahn, Bo http://orcid.org/0000-0002-3457-6249
Jensen, Lars Thorbjørn
Johansen, Christoffer http://orcid.org/0000-0002-4384-206X
Dalton, Susanne Oksbjerg http://orcid.org/0000-0002-5485-2730
Funding for this research was provided by:
TRYG Fonden (112305)
Kræftens Bekæmpelse (R96-A6604-14-S22)
Article History
Received: 9 December 2022
Accepted: 19 April 2023
First Online: 1 May 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. All participants gave written informed consent before any initiation of study activities. The trial was approved by the Danish Health and Medicines Authority as a trial including medicinal gas (EUDRACT no. 2015–000604-25), and the Ethical committee of the Capitol Region (No. R96-A6604-14-S22).
: Not applicable.
: The authors declare no competing interests.